Home
Submit
Login
Search
TARA
School of Medicine
Clinical Medicine
Search
TARA
School of Medicine
Clinical Medicine
Search
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browse
All of TARA
Academic/Research Units & Collections
Titles
Authors
Date of Publication
Subjects
Sponsor
This Academic/Research Unit
Titles
Authors
Date of Publication
Subjects
Sponsor
Discover
Author
O'BYRNE, KEN (27)
GRAY, STEVEN (7)
BARR, MARTIN (5)
BAIRD, ANNE-MARIE (3)
GATELY, KATHY (2)
DOHERTY, DEREK (1)
O'DONNELL, DEARBHAILE (1)
Subject
Cancer (15)
Oncology (5)
cancer (3)
epigenetics (3)
Biomedical sciences (2)
cisplatin (2)
Genes & Society (2)
lung cancer (2)
non-small cell lung cancer (2)
acetylation (1)
... View More
Date Issued
2017 (6)
2016 (5)
2014 (4)
2013 (7)
2011 (5)
Sponsor
Wellcome Trust Fellowship (1)
Search
Go
Advanced Search
Use advanced search to refine the search results.
Reset
Add New Filter
Apply
Now showing items 21-27 of 27
Sort Options:
Relevance
Title Asc
Title Desc
Issue Date Asc
Issue Date Desc
Author Asc
Author Desc
Results Per Page:
5
10
20
40
60
80
100
Epigenetic Regulation of Glucose Transporters in Non-Small Cell Lung Cancer
O'BYRNE, KEN
;
BAIRD, ANNE-MARIE
;
GRAY, STEVEN
(
MDPI
,
2011
)
The role of epigenetics in resistance to cisplatin chemotherapy in lung cancer
GRAY, STEVEN
;
BARR, MARTIN
;
O'BYRNE, KEN
(
2011
)
Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
BARR, MARTIN
;
O'BYRNE, KEN
(
2017
)
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: Overall survival data from the phase IIb LUX-Lung 7 trial
O'BYRNE, KEN
(
2017
)
hSSB1 associates with and promotes stability of the BLM helicase
O'BYRNE, KEN
(
2017
)
hSSB1 phosphorylation is dynamically regulated by DNA-PK and PPP-family protein phosphatases
O'BYRNE, KEN
(
2017
)
Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial
O'BYRNE, KEN
(
2017
)
«
1
2
3